Wang Yan, Vincent Robert, Yang Jinlian, Asgharpour Amon, Liang Xieer, Idowu Michael O, Contos Melissa J, Daitya Kalyani, Siddiqui Mohammed S, Mirshahi Faridoddin, Sanyal Arun J
Department of Infectious Diseases & Hepatology Unit, Southern Medical University Nanfang Hospital, GZ China.
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA.
Hepatology. 2017 Jun;65(6):1891-1903. doi: 10.1002/hep.29090. Epub 2017 Apr 28.
There is a need for further refinement of current histological systems for assessment of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). This study evaluated hepatic fibrosis in NAFLD using dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FPs). Fifty test cohort subjects and 42 validation cohort subjects with NAFLD and the full spectrum of fibrosis were studied. q-FPs were measured in specific predefined regions of interest (general, vessel, perisinusoid, and vascular septa). Seventy q-FPs had inter- and intraobserver concordance ≥0.8 and were related to the NASH Clinical Research Network fibrosis staging. Of these, 16 q-FPs with the strongest correlations (P < 0.001 for all) were entered in a principal component analysis model (odds ratio [OR] 7.8, P < 0.001), which separated any stage of fibrosis versus no fibrosis, and cirrhosis versus earlier stages with the areas under the receiver operating characteristic curves of 0.88 and 0.93 (P ≤ 0.01 for both), respectively. In an independent multivariable analysis, four q-FPs-the number of collagen strands (OR 8.5, P = 0.004), strand length (OR 12.0, P = 0.02), strand eccentricity (OR 8.3, P = 0.004), and strand solidity (OR 8.0, P = 0.003)-were independently associated with fibrosis stages and were used to model fibrosis along a continuous linear scale using desirability functions; this linear scale of fibrosis measurement was also related to fibrosis stage (P < 0.0001). The robustness of both the multivariable model and the linear scale of measurement was confirmed in the validation cohort.
The q-FP model provides an accurate reproducible method to evaluate fibrosis in NAFLD along a quantitative and continuous scale. (Hepatology 2017;65:1891-1903).
当前用于评估非酒精性脂肪性肝病(NAFLD)肝纤维化的组织学系统需要进一步完善。本研究使用基于双光子显微镜的纤维化相关参数定量(q-FPs)来评估NAFLD中的肝纤维化。对50名测试队列受试者和42名验证队列受试者进行了研究,这些受试者患有NAFLD且纤维化程度各异。在特定的预定义感兴趣区域(一般区域、血管、窦周和血管间隔)测量q-FPs。70个q-FPs的观察者间和观察者内一致性≥0.8,且与NASH临床研究网络纤维化分期相关。其中,16个相关性最强的q-FPs(所有P<0.001)被纳入主成分分析模型(优势比[OR]7.8,P<0.001),该模型可区分任何纤维化阶段与无纤维化阶段,以及肝硬化与早期阶段,受试者工作特征曲线下面积分别为0.88和0.93(两者P≤0.01)。在独立多变量分析中,四个q-FPs——胶原纤维束数量(OR 8.5,P = 0.004)、纤维束长度(OR 12.0,P = 0.02)、纤维束偏心率(OR 8.3,P = 0.004)和纤维束坚实度(OR 8.0,P = 0.003)——与纤维化阶段独立相关,并使用合意函数沿连续线性尺度对纤维化进行建模;这种纤维化测量的线性尺度也与纤维化阶段相关(P<0.0001)。多变量模型和测量线性尺度在验证队列中均得到了验证。
q-FP模型提供了一种准确、可重复的方法,可沿定量和连续尺度评估NAFLD中的纤维化。(《肝脏病学》2017年;65:1891 - 1903)